201 related articles for article (PubMed ID: 8856730)
1. Increased inorganic mercury in spinal motor neurons following chelating agents.
Ewan KB; Pamphlett R
Neurotoxicology; 1996; 17(2):343-9. PubMed ID: 8856730
[TBL] [Abstract][Full Text] [Related]
2. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
Juresa D; Blanusa M; Kostial K
Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
[TBL] [Abstract][Full Text] [Related]
4. Effects of chelators on mercury, iron, and lead neurotoxicity in cortical culture.
Rush T; Hjelmhaug J; Lobner D
Neurotoxicology; 2009 Jan; 30(1):47-51. PubMed ID: 19027035
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid.
Bridges CC; Joshee L; Zalups RK
J Pharmacol Exp Ther; 2008 Jan; 324(1):383-90. PubMed ID: 17940195
[TBL] [Abstract][Full Text] [Related]
6. MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR(-) and control rats exposed to thiol S-conjugates of inorganic mercury.
Bridges CC; Joshee L; Zalups RK
Toxicol Sci; 2008 Sep; 105(1):211-20. PubMed ID: 18511429
[TBL] [Abstract][Full Text] [Related]
7. 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.
Nogueira CW; Soares FA; Nascimento PC; Muller D; Rocha JB
Toxicology; 2003 Mar; 184(2-3):85-95. PubMed ID: 12499112
[TBL] [Abstract][Full Text] [Related]
8. Inorganic mercury is transported from muscular nerve terminals to spinal and brainstem motoneurons.
Arvidson B
Muscle Nerve; 1992 Oct; 15(10):1089-94. PubMed ID: 1383815
[TBL] [Abstract][Full Text] [Related]
9. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid, and meso-2,3-dimercaptosuccinic acid inhibit delta-aminolevulinate dehydratase from human erythrocytes in vitro.
Nogueira CW; Santos FW; Soares FA; Rocha JB
Environ Res; 2004 Mar; 94(3):254-61. PubMed ID: 15016592
[TBL] [Abstract][Full Text] [Related]
10. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury.
George GN; Prince RC; Gailer J; Buttigieg GA; Denton MB; Harris HH; Pickering IJ
Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232
[TBL] [Abstract][Full Text] [Related]
11. Does selenium deficiency unmask mercury toxicity in motor neurons?
Pamphlett R; Eide R; Danscher G
Neurotoxicol Teratol; 2005; 27(2):241-4. PubMed ID: 15734275
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effectiveness of 2,3-dimercaptopropanol (BAL) and meso-2,3-dimercaptosuccinic acid (DMSA) as protective agents against mercuric chloride-induced nephrotoxicity in rats.
de la Torre A; Bellés M; Llobet JM; Mayayo E; Domingo JL
Biol Trace Elem Res; 1998 Jul; 63(1):1-10. PubMed ID: 9764565
[TBL] [Abstract][Full Text] [Related]
13. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride.
Gonzalez-Ramirez D; Zuniga-Charles M; Narro-Juarez A; Molina-Recio Y; Hurlbut KM; Dart RC; Aposhian HV
J Pharmacol Exp Ther; 1998 Oct; 287(1):8-12. PubMed ID: 9765315
[TBL] [Abstract][Full Text] [Related]
14. Cadmium inhibits delta-aminolevulinate dehydratase from rat lung in vitro: interaction with chelating and antioxidant agents.
Luchese C; Zeni G; Rocha JB; Nogueira CW; Santos FW
Chem Biol Interact; 2007 Jan; 165(2):127-37. PubMed ID: 17187767
[TBL] [Abstract][Full Text] [Related]
15. DMPS and N-acetylcysteine induced renal toxicity in mice exposed to mercury.
Brandão R; Santos FW; Zeni G; Rocha JB; Nogueira CW
Biometals; 2006 Aug; 19(4):389-98. PubMed ID: 16841248
[TBL] [Abstract][Full Text] [Related]
16. Efforts to control the errant products of a targeted in vivo generator.
Jaggi JS; Kappel BJ; McDevitt MR; Sgouros G; Flombaum CD; Cabassa C; Scheinberg DA
Cancer Res; 2005 Jun; 65(11):4888-95. PubMed ID: 15930310
[TBL] [Abstract][Full Text] [Related]
17. Chelation in metal intoxication. XX: Effect of pre-treatment with chelators on the distribution of mercury.
Kachru DN; Tandon SK
Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):399-402. PubMed ID: 3016847
[TBL] [Abstract][Full Text] [Related]
18. Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review.
Muran PJ
Altern Ther Health Med; 2006; 12(3):70-5. PubMed ID: 16708769
[TBL] [Abstract][Full Text] [Related]
19. The influence of chelating agents on the distribution and biotransformation of methylmercuric chloride in rats.
Planas-Bohne F
J Pharmacol Exp Ther; 1981 May; 217(2):500-4. PubMed ID: 6262488
[TBL] [Abstract][Full Text] [Related]
20. Antidotal effects of 2,3-dimercaptopropane-1-sulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the organotoxicity of dibutyltin dichloride (DBTC) in rats.
Merkord J; Weber H; Kröning G; Hennighausen G
Hum Exp Toxicol; 2000 Feb; 19(2):132-7. PubMed ID: 10773844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
